Algae Omega-3 Ingredients Market Size
The Algae Omega-3 Ingredients Market was US$ 913.0 Million in 2025 and is expected to reach US$ 1,485.5 Million in 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).
The omega-3 fatty acid is an essential fatty acid required by the human body for normal functioning and brain development. Ongoing research and development on omega-3 fatty acids have become vital to the food, pharmaceutical, and feed industries. The algae omega-3 application is growing at a faster rate than the infant food fortification as it provides the same benefit as that of the fish oil but with no taste or odor. Also, the increased consumption of omega-3 supplements is responsible for market growth. Globally, algae omega-3 ingredients are gaining prominence and becoming a part of the consumer’s daily diet.
One of the most important nutrients in the human diet is omega-3 fatty acids. Omega-3 fats have strong, positive health effects. For instance, observational studies have connected inflammation and depression with higher omega-6 and lower omega-3 fats.
A recent study found that omega-3 supplementation could lower inflammation and anxiety even among healthy young adults. Further, in another study published in the Journal of the International Society of Sports Nutrition, 44 women and men who supplemented their diets with either safflower oil or omega-3 fatty acids were examined. After 6 weeks of supplementation, the omega-3 supplemented group saw a decrease in body fat and an increase in fat-free mass compared to the safflower oil group. The study found a significant correlation between these changes and a decline in salivary cortisol, a stress hormone. Another study discovered that consuming omega-3 fatty acids during rigorous wrestling training can enhance athletes' lung function during and after exercise.
An individual's omega-3 status and the quantity of EPA and DHA needed for optimal cellular health depend on various factors. A supplement consisting of 3000 to 4000 mg of EPA and DHA daily should be sufficient support for the majority of healthy adults and, more importantly, act as a buffer against the competitive effects of factors impeding omega-3 metabolism.
Algae Omega-3 Ingredients Market : Key Takeaways
- USD 1.49 billion is the 2033 market opportunity. The market is projected to expand from USD 913.0 million in 2025 to USD 1,485.5 million by 2033, driven by increasing demand for sustainable, plant-based omega-3 ingredients across nutrition, food, feed and pharmaceutical applications.
- North America leads market adoption, while Asia-Pacific delivers the fastest growth. Strong consumer awareness, established dietary supplement industries and continuous product innovation support North America's leadership, whereas rising health consciousness and expanding nutraceutical manufacturing accelerate growth across Asia-Pacific.
- Plant-based nutrition is transforming omega-3 sourcing. Consumers are increasingly replacing traditional fish-derived omega-3 with algae-based DHA and EPA due to sustainability, vegan preferences, cleaner labeling and concerns over marine resource depletion.
- Dietary supplements remain the primary demand engine. Growing awareness of cardiovascular, cognitive, prenatal and eye health benefits is increasing the incorporation of algae-derived omega-3 ingredients into capsules, functional foods and fortified beverages.
- Infant nutrition continues to drive premium ingredient demand. Manufacturers are expanding the use of algae-derived DHA in infant formula to provide essential brain and visual development benefits while offering a vegetarian alternative to fish oil.
- EPA innovation is expanding commercial opportunities. Advances in microalgae cultivation and fermentation technologies are enabling higher-purity EPA production, supporting applications in pharmaceuticals, clinical nutrition and premium dietary supplements.
- Fermentation and biotechnology are improving scalability. Controlled algae cultivation, precision fermentation and sustainable production methods are enhancing yield consistency, reducing environmental impact and strengthening long-term supply security.
- Sustainability is becoming a competitive differentiator. Algae-derived omega-3 ingredients eliminate dependence on wild fish stocks, reduce pressure on marine ecosystems and support ESG goals, making them increasingly attractive to food, nutraceutical and pharmaceutical manufacturers.
Algae Omega-3 Ingredients Market Sope
| Metrics | Details |
| Market CAGR | 7.4% |
| Segments Covered | By Type, By Application, By Form Type, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Algae Omega-3 Ingredients Market Dynamics
Increased demand for infant formula products
Infant formula grew 86% in Feb 2020 in China while baby food demand grew by 98% after the Covid-19 impact due to the high demand for baby products. China accounts for 30% of the global consumption of Infant formula which is followed by other Asian countries holding 28% of the market. About 65% of the growth in the Infant formula market comes from China. In 2015, china imported 180 Kilo Tones of Infant formula from the world which is valued to be USD 2.4 billion. Europe accounts for about 90% of the import share. In addition, due to a recent scandal of domestically produced low-quality products, consumers of baby formula products are moving towards imported formula in the market. DHA and EPA are essential for infant brain development and immunity strength. DHA has well-established legal strains for incorporation into infant formula products in different regulations and WHO recommendations.
According to a Norwegian study, omega-3 demonstrates a positive effect on a child's brain and enhances a child’s problem-solving abilities. According to recent research studies, high doses of DHA in baby formula or breast milk can have a positive effect on the growth of preterm infants, such as an increase in height. In countries such as China, where both the adult population and infant population are on the rise, the demand for infant nutrition and baby food is constantly increasing. The demand for infant nutrition fortified with omega-3 is increasing among parents who have busy lifestyles and less time to prepare meals.
However, the rising cost of raw materials, especially natural ingredients, has made a dent in the profit margins of many small-scale suppliers. This situation is more precarious for suppliers who are sourcing from China, India, and the U.S. Furthermore, fluctuating input costs and labor costs have also influenced the profitability margin of the suppliers and distributors and continue to surge. Additionally, the lack of consistent standards and guidelines in the global EPA/DHA (Omega3) ingredients market is also one of the defining factors that restrain the market growth. Regulations vary from country to country regarding the use of EPA / DHA (Omega 3) and its inclusion under the food category. Lack of regulations could lead to misuse of claims indicating health benefits.
Algae Omega-3 Ingredients Market Segmentation
The docosahexaenoic Acid (DHA) segment is expected to dominate the global algae omega-3 ingredients market, by type
The Docosahexaenoic Acid (DHA) in Global Algae Omega-3 Ingredients Market has reached US$ 325.46 Million in 2020 and is expected to reach US$ 538.04 Million by 2029. DHA is a fatty acid rich in Omega-3 and is a major component of the human brain's cerebral cortex, the skin and the retina. The chemical formula of DHA is C₂₂H₃₂O₂. DHA has a carboxylic acid structure with a 22-carbon chain and six cis-double bonds. DHA accounts for up to 97% of the total omega-3 fats in the brain and up to 93% of the omega-3 fats in specific parts of the eye retina. The human body can't make its omega-3 fatty acids and therefore requires external supplementation.
Regular intake of DHA is shown to have a beneficial impact on cardiovascular health. DHA is widely used in medications used to treat excessive blood cholesterol or other lipids (fats) (hyperlipidemia). Phosphatidylserine (PS), which has high DHA content, is found to have roles in neuron signaling and neurotransmission. DHA supplementation is used to improve thinking and memory skills, promote newborn and child development, treat some eye abnormalities and treat various other ailments. Research is ongoing to ascertain DHA's concrete benefits on the human body. The mentioned advantages of DHA are the prime cause of the product's market growth in recent times.
Foods and supplements high in omega-3 are recommended for the diets of pregnant and lactating women. The International Society for the Study of Fatty Acids and Lipids (ISSFAL) recommends the intake of 300mg/day of DHA for pregnant and breastfeeding women.
Ethyl Esters in Algae Omega-3: Driving Innovation in Nutrition and Biofuels
The with smllest share, ethyl esters segment in the global algae omega-3 ingredients market is witnessing robust growth. Valued at US$ 18.47 million in 2024, it is projected to reach US$ 28.72 million by 2029. This growth reflects the increasing demand for omega-3 fatty acids in dietary supplements, pharmaceuticals, and functional foods due to their established role in cardiovascular health and overall wellness.
Microalgae serve as an indispensable food source during various growth stages of mollusks, crustaceans, and numerous fish species. Beyond nutrition, eukaryotic microalgae have been found to contain a diverse range of bioactive compounds such as carotenoids, pigments, polyphenols, and lipids. These compounds are not only valuable in aquaculture but also hold immense potential in nutraceutical and pharmaceutical applications.
Lipids extracted from microalgae biomass present a sustainable resource with multiple applications. These lipids can be converted into fatty acid ethyl esters, bioethanol, biohydrogen, and thermochemical products like bio-oil and bio-crude. Importantly, omega-3-acid ethyl esters play a critical role in reducing high blood triglyceride levels when used with a proper diet. By lowering the risk of clogged blood vessels, these compounds help prevent severe medical conditions, including heart attacks and strokes.
Research and technological advances are further supporting the adoption of ethyl ester forms. A significant study conducted in 2020 by the Fraunhofer IGB research institute demonstrated successful cultivation of algal cells using mineral salts, artificial light, and CO₂ in photobioreactors. Within these systems, Eicosapentaenoic Acid (EPA) is formed in the chloroplast membranes of microalgae as Monogalactosyldiglycerol (MGDG). To be used in dietary supplements, EPA must be separated from galactolipids and enzymatically esterified with ethanol, resulting in EPA ethyl ester, which is a stable and bioavailable form.
In addition, a July 2021 study published in The Journal of Food Science and Nutrition highlighted the benefits of Docosahexaenoic Acid (DHA) in ethyl ester form, showing that daily supplementation with 850–1000mg can provide measurable improvements in cardiovascular health. These findings emphasize the importance of ethyl esters in advancing clinical and consumer applications of algae-derived omega-3.
Algae Omega-3 Ingredients Market Geographical Share
North America is the largest market for algae omega-3 ingredients with a share of nearly 45.21% in 2024
North America algae omega-3 ingredients market is valued at US$ 383.20 Million in 2024 and is estimated to reach US$ 523.29 Million by 2029. Essential fatty acids called omega-3 oils have a variety of health advantages, including improved heart, eye and brain function. A growing number of vegans and others seeking a source of long-chain omega-3 fatty acids are turning to algae oil (EPA and DHA). Pollutant contamination with substances like polychlorinated biphenyls is not a concern.
The main driver of market growth is innovation, both in terms of products and technologies. Furthermore, the government has put a strong system in place for the food labeling regulations for nutritious goods. U.S. holds the biggest proportion of North America's algal omega 3 ingredients market. It results from rising Omega 3 supplements, food intake and public knowledge of the substance's health advantages. Additionally, the top businesses' domestic expansion and regular product launches with improved formulas have stoked the regional market's growth.
Docosahexaenoic acid (DHA) is a crucial component of newborn feeding in U.S. Almost all of the companies selling infant formula in the nation include DHA as an ingredient, raising the price of the formula and contributing to the market expansion for algae-based omega-3 components. The American Heart Association compared deaths brought on by coronary illnesses using data from U.S. and Japan. The statistics for 2021 showed more deaths from coronary disease in U.S. than in Japan. Consumers are compelled to reconsider their eating habits due to the rising prevalence of numerous chronic diseases.
Algae Omega-3 Ingredients Companies and Competitive Landscape
The global algae omega-3 ingredients market is fragmented, as key players, like Koninklijke DSM N.V, Corbion, BASF, Polaris S.A., and Neptune Wellness Solutions Inc. are facing competition from local players across various regions. Partnerships remained the most common strategy. Key players, like ADM, Koninklijke DSM N.V, and Neptune Wellness Solutions Inc. are focusing on partnerships and joint ventures to increase their production capabilities and consumer base across various regions.
Moreover, other small players are also showing keen interest in the market due to the virtue of its wider array of applications in the pharmaceutical, nutraceutical, and food & beverage industries. For instance, in January 2019, Epax committed to investing 35 million USD to expand its omega-3 production capacity at its main facility in Norway allowing it to increase by 50% by 2021. In May 2020, DSM has expanded its nutrition portfolio with ARA and DHA powder which is especially for infant nutrition. This powder contains a minimum of 110 mg DHA and ARA.
Furthermore, it is sourced from sustainable vegetarian DHA omega-3 and ARA omega-6 which aid to meet the global sustainable demands. In March 2020, Wiley companies introduced its first omega-3 concentrate in powdered form which has been designed for dietary supplements, food, and beverages. The product has been developed without a fishy smell or taste to appeal to consumers looking for attractive sensorial products.
Recent Industry Developments in Algae Omega‑3 Ingredients Market (2026–2025)
- In 2026, demand for algae‑based omega‑3 ingredients continued strong growth as consumers and formulators increasingly preferred plant‑based, sustainable alternatives to fish oil for cardiovascular, cognitive, and prenatal nutrition applications.
- In 2026, proprietary cultivation and extraction technologies such as heterotrophic fermentation and cold‑press methods advanced, enabling higher DHA/EPA concentration yields and lower production costs, improving commercial competitiveness.
- In early 2026, manufacturers focused on transparent sourcing and certification (e.g., non‑GMO, organic, clean label) to meet stringent regulatory and consumer expectations for purity, traceability, and environmental sustainability.
- In 2025, companies such as DSM-Firmenich, Cargill, and Qualitas Health expanded product portfolios with high‑concentration algae DHA/EPA oils formulated for supplements, functional foods, and beverages.
- In 2025, the plant‑based dietary supplement segment remained a key demand driver as consumers shifted toward vegan, sustainable, and allergen‑friendly omega‑3 sources, especially in North America and Europe.
- In 2025, regulatory approvals and health claims expansion such as heart and eye health benefits supported by EFSA and FDA qualified health claims boosted confidence and adoption among formulators and consumers.
- In 2025, Asia‑Pacific emerged as a high‑growth region for algae omega‑3 ingredients due to increasing health awareness, rising disposable income, and expanding retail and e‑commerce channels for dietary supplements and fortified foods.
- In 2025, collaboration between ingredient manufacturers and branded supplement makers accelerated innovation and product launches featuring algae omega‑3 in gummy, capsule, liquid, and functional beverage formats, broadening consumer choice and market reach.
Key Procurement Priorities and Buyer Evaluation Criteria
- The procurement decision-making process is increasingly influenced by rising consumer demand for sustainable plant-based nutrition, expanding applications of algae-derived omega-3 ingredients in dietary supplements, infant formula, pharmaceuticals, functional foods, and animal nutrition, along with growing regulatory support for vegan and allergen-free alternatives. Buyers prioritize suppliers capable of ensuring consistent product quality, traceability, and scalable production.
- Buyers evaluate factors such as DHA and EPA concentration, purity levels, bioavailability, oxidative stability, contaminant-free production, sensory profile, certifications (Non-GMO, Vegan, Organic, Halal, Kosher), and compliance with international food safety and nutraceutical regulations when selecting algae omega-3 ingredient suppliers.
- The buyer considers cultivation technology, microalgae strain selection, extraction and purification methods, manufacturing scalability, supply chain reliability, formulation support, customized ingredient offerings, and research-backed efficacy while choosing long-term technology and ingredient partners for commercial production.
- Procurement decisions are also shaped by sustainability objectives, with buyers assessing suppliers based on carbon footprint reduction, responsible algae cultivation practices, water-efficient production technologies, renewable energy utilization, recyclable packaging, and adherence to environmental and ESG standards as manufacturers increasingly focus on sustainable sourcing and clean-label product development.
Why Choose DataM?
Technological Innovations
Explores advancements in algae cultivation technologies, precision fermentation, closed-loop photobioreactor systems, advanced extraction and purification techniques, encapsulation technologies, and high-purity DHA and EPA production processes, enabling improved product stability, higher yields, enhanced nutritional value, and cost-effective commercial manufacturing.
Product Performance & Market Positioning
Evaluates how leading companies differentiate their algae omega-3 ingredient portfolios based on DHA and EPA concentration, purity, oxidation resistance, bioavailability, sensory characteristics, clean-label positioning, formulation flexibility, regulatory approvals, and suitability for dietary supplements, functional foods, infant nutrition, pharmaceuticals, and animal feed applications.
Real-World Evidence
Highlights the increasing adoption of algae omega-3 ingredients across dietary supplements, infant formula, dairy alternatives, plant-based foods, beverages, pharmaceuticals, aquaculture feed, and pet nutrition, demonstrating benefits such as sustainable sourcing, vegetarian compatibility, reduced marine dependence, and improved cardiovascular, cognitive, and eye health.
Market Updates & Industry Changes
Tracks key developments including production capacity expansions, strategic partnerships, investments in microalgae cultivation facilities, technological innovations in algae processing, regulatory approvals, new product launches, and regional expansion across North America, Europe, Asia-Pacific, and Latin America, supporting the growing global demand for sustainable omega-3 nutrition.
Competitive Strategies
Analyzes how leading companies strengthen their market presence through product innovation, strategic collaborations, acquisitions, manufacturing expansion, proprietary cultivation technologies, clean-label product development, sustainable sourcing initiatives, and partnerships with food, beverage, nutraceutical, pharmaceutical, and animal nutrition manufacturers.
Pricing & Market Access
Explains pricing variations based on algae species, DHA/EPA concentration, production technology, extraction process, purity standards, certifications, formulation type (oil or powder), packaging formats, and commercial scale, along with market access through ingredient distributors, nutraceutical manufacturers, food ingredient suppliers, pharmaceutical companies, and direct B2B partnerships.
Market Entry & Expansion
Identifies growth opportunities driven by increasing vegan and vegetarian populations, rising demand for sustainable nutrition, expanding functional food markets, infant nutrition innovations, aquaculture sustainability initiatives, and growing consumer awareness of omega-3 health benefits, while outlining strategies including regional production expansion, product differentiation, certification acquisition, strategic partnerships, and investment in next-generation algae cultivation technologies.
Target Audience
- Dietary Supplement Manufacturers
- Functional Food & Beverage Manufacturers
- Infant Formula Manufacturers
- Pharmaceutical & Nutraceutical Companies
- Algae Omega-3 Ingredient Producers
- Food Ingredient Distributors & Suppliers
- Animal Nutrition & Aquaculture Feed Manufacturers
- Contract Manufacturers (CDMOs/CMOs)
- Retail & Private Label Nutrition Brands
- Research Institutes & Biotechnology Companies
- Investors & Venture Capital Firms
- Regulatory Authorities & Food Safety Organizations
- Healthcare & Nutrition Professionals
- E-commerce & Health Product Retailers
- Food Processing & Ingredient Innovation Companies
